Tang Hongli, Wu Leiruo, Chen Xixi, Li Huiting, Huang Baojun, Huang Zhenyang, Zheng Yiyang, Zhu Liqing, Geng Wujun
Anesthesiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
Endoscopy Center, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
PeerJ. 2021 May 28;9:e10921. doi: 10.7717/peerj.10921. eCollection 2021.
Microglia, neuron, and vascular cells constitute a dynamic functional neurovascular unit, which exerts the crucial role in functional recovery after ischemic stroke. Paeoniflorin, the principal active component of Paeoniae Radix, has been verified to exhibit neuroprotective roles in cerebralischemic injury. However, the mechanisms underlying the regulatory function of Paeoniflorin on neurovascular unit after cerebral ischemia are still unclear.
In this study, adult male rats were treated with Paeoniflorin following transient middle cerebral artery occlusion (tMCAO), and then the functional behavioral tests (Foot-fault test and modified improved neurological function score, mNSS), microglial activation, neurogenesis and vasculogenesis were assessed.
The current study showed that Paeoniflorin treatment exhibited a sensorimotor functional recovery as suggested via the Foot-fault test and the enhancement of spatial learning as suggested by the mNSS in rat stroke model. Paeoniflorin treatment repressed microglial cell proliferation and thus resulted in a significant decrease in proinflammatory cytokines IL-1, IL-6 and TNF-. Compared with control, Paeoniflorin administration facilitated von Willebrand factor (an endothelia cell marker) and doublecortin (a neuroblasts marker) expression, indicating that Paeoniflorin contributed to neurogenesis and vasculogenesis in rat stroke model. Mechanistically, we verified that Paeoniflorin repressed JNK and NF-B signaling activation.
These results demonstrate that Paeoniflorin represses neuroinflammation and facilitates neurogenesis in rat stroke model and might be a potential drug for the therapy of ischemic stroke.
小胶质细胞、神经元和血管细胞构成一个动态的功能性神经血管单元,其在缺血性中风后的功能恢复中发挥关键作用。芍药苷是芍药根的主要活性成分,已被证实对脑缺血损伤具有神经保护作用。然而,芍药苷对脑缺血后神经血管单元的调节作用机制仍不清楚。
在本研究中,成年雄性大鼠在短暂大脑中动脉闭塞(tMCAO)后接受芍药苷治疗,然后评估其功能行为测试(足误测试和改良的神经功能评分,mNSS)、小胶质细胞活化、神经发生和血管生成。
当前研究表明,在大鼠中风模型中,芍药苷治疗通过足误测试显示出感觉运动功能恢复,通过mNSS显示出空间学习能力增强。芍药苷治疗抑制了小胶质细胞增殖,从而导致促炎细胞因子IL-1、IL-6和TNF-显著降低。与对照组相比,芍药苷给药促进了血管性血友病因子(一种内皮细胞标志物)和双皮质素(一种神经母细胞标志物)的表达,表明芍药苷有助于大鼠中风模型中的神经发生和血管生成。从机制上讲,我们证实芍药苷抑制了JNK和NF-κB信号激活。
这些结果表明,芍药苷在大鼠中风模型中抑制神经炎症并促进神经发生,可能是治疗缺血性中风的潜在药物。